CODX vs DD
Co-Diagnostics, Inc. Common Stock (CODX) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CODX currently screens at market cap $31.4M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CODX and DD stock pages for the full models.
Not investment advice.